Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on: December 26,2023

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on:December 26,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on: December 20,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on:December 20,2023

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi

Updated on: December 19,2023

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi

Updated on:December 19,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on: December 21,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on:December 21,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on: December 19,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on:December 19,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on: December 18,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on:December 18,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on: December 19,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on:December 19,2023

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell

Updated on: October 27,2023

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell

Updated on:October 27,2023

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America

Updated on: December 19,2023

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America

Updated on:December 19,2023

BRAF Mutation: Cancer Types, Testing, Treatment

BRAF Mutation: Cancer Types, Testing, TreatmentRole of BRAF mutations in melanoma, lung cancer, and moreByLynne Eldridge, MDUpdated on October 14, 2022Medically reviewed byOliv

Updated on: January 28,2024

BRAF Mutation: Cancer Types, Testing, Treatment

BRAF Mutation: Cancer Types, Testing, TreatmentRole of BRAF mutations in melanoma, lung cancer, and moreByLynne Eldridge, MDUpdated on October 14, 2022Medically reviewed byOliv

Updated on:January 28,2024

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

Updated on: December 20,2023

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

Updated on:December 20,2023

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on: January 06,2024

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on:January 06,2024